{"entity":{"type":"insider","cik":"0001855689","url":"/insider/0001855689","json_url":"/insider/0001855689.json","name":"Townson Sharon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2026-01-05","last":"2026-07-07","span_basis":"filed_date"},"name_variants":[{"name":"Townson Sharon","source":"filing","n_filings":5,"first_seen":"2026-01-05","last_seen":"2026-07-07"}],"transactions":[{"id":5920433,"accession":"0001193125-26-297558","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-297558","line_url":"/filing/0001193125-26-297558","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001855689","owner_name":"Townson Sharon","owner_display_name":"Townson Sharon","owner_url":"/insider/0001855689","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":23.3082,"price_display":"23.31","price_state":"stated","total_value":139849.2,"total_display":"139,849.20","total_whole":"139,849","shares_owned_after":68245.0,"shares_owned_after_display":"68,245","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-06","filed_date":"2026-07-07","scope":"insider","n_lines":2},{"id":5798249,"accession":"0001193125-26-282736","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-282736","line_url":"/filing/0001193125-26-282736#line-2","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001855689","owner_name":"Townson Sharon","owner_display_name":"Townson Sharon","owner_url":"/insider/0001855689","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":60000.0,"total_display":"60,000.00","total_whole":"60,000","shares_owned_after":67845.0,"shares_owned_after_display":"67,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-23","filed_date":"2026-06-25","scope":"insider"},{"id":6089014,"accession":"0001193125-26-275805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-275805","line_url":"/filing/0001193125-26-275805#line-2","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001855689","owner_name":"Townson Sharon","owner_display_name":"Townson Sharon","owner_url":"/insider/0001855689","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":57000.0,"total_display":"57,000.00","total_whole":"57,000","shares_owned_after":67845.0,"shares_owned_after_display":"67,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":6154015,"accession":"0001193125-26-251395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-251395","line_url":"/filing/0001193125-26-251395#line-2","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001855689","owner_name":"Townson Sharon","owner_display_name":"Townson Sharon","owner_url":"/insider/0001855689","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":19.87,"price_display":"19.87","price_state":"stated","total_value":119220.0,"total_display":"119,220.00","total_whole":"119,220","shares_owned_after":67845.0,"shares_owned_after_display":"67,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-01","scope":"insider"},{"id":5809228,"accession":"0001193125-26-002385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-002385","line_url":"/filing/0001193125-26-002385#line-2","is_derivative":false,"issuer_cik":"0001826457","issuer_name":"Monte Rosa Therapeutics, Inc.","issuer_ticker":"GLUE","issuer_name_source":null,"issuer_url":"/issuer/0001826457","owner_cik":"0001855689","owner_name":"Townson Sharon","owner_display_name":"Townson Sharon","owner_url":"/insider/0001855689","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3155.0,"shares_display":"3,155","price_per_share":15.17,"price_display":"15.17","price_state":"stated","total_value":47861.35,"total_display":"47,861.35","total_whole":"47,861","shares_owned_after":67845.0,"shares_owned_after_display":"67,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001826457","name":"Monte Rosa Therapeutics, Inc.","url":"/issuer/0001826457","role":"Officer (Chief Scientific Officer)","n_filings":5,"first_seen":"2026-01-05","last_seen":"2026-07-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001855689","retrieved_at":"2026-08-26T02:18:34+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}